ANI Pharmaceuticals Inc. (ANIP)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 1 |
Ownership rank: | 706 |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
39 |
$26,261,732 |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
23 Mar 2022 |
LALWANI NIKHIL |
PRESIDENT & CEO |
21 Mar 2022 |
7,224 |
27.69 |
199,997 |
22 Mar 2022 |
WALSH PATRICK D |
Director |
21 Mar 2022 |
5,000 |
27.76 |
138,794 |
22 Mar 2022 |
GASSERT CHAD |
SVP - CORP. DEV. & STRATEGY |
21 Mar 2022 |
5,000 |
27.87 |
139,342 |
22 Mar 2022 |
GASSERT CHAD |
SVP - CORP. DEV. & STRATEGY |
18 Mar 2022 |
5,000 |
27.15 |
135,744 |
21 Mar 2022 |
SHANMUGAM MUTHUSAMY |
HEAD OF R&D, COO-NOVITIUM OPS |
17 Mar 2022 |
5,000 |
27.65 |
138,252 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock